Company Overview and News

 
Orion Minerals upgrades world-class zinc-copper deposit in South Africa

2018-04-09 proactiveinvestors.com.au
Orion Minerals Ltd (ASX:ORN) has established a maiden resource of 5.2 million tonnes containing 253,000 tonnes zinc and 67,000 tonnes copper for the Vardocube area within the Prieska project in South Africa.
Upvote Downvote

 
Orion Minerals readies to test potential world-class VMS deposit

2017-10-25 proactiveinvestors.com.au
Orion Minerals NL (ASX:ORN,JSE:ORN) snapped up the Prieska project in South Africa in 2015 at the bottom of the cycle, which is part of a 1790 square kilometre land package.
Upvote Downvote

 
Orion Minerals NL to lift cash for South African zinc-copper hunt

2017-08-15 proactiveinvestors.com.au
Orion Minerals NL (ASX:ORN) made an opportunistic move in 2015, acting in the bottom of the commodities cycle to secure a 1790 square kilometre land package in a proven mineralised district of South Africa.
Upvote Downvote

 
Orion Minerals NL secures cornerstone investment from Tembo Capital

2017-05-31 proactiveinvestors.com.au
Orion Minerals NL (ASX:ORN) got a major boost to its base metal development strategy in South Africa after Tembo Capital Mining Fund committed a $3 million investment in Orion.
Upvote Downvote

 
Tembo invests in Orion

2017-05-31 businessnews.com.au
Zinc and copper explorer Orion Minerals has received a $3 million investment by private equity group Tembo Capital to fund work at its projects in Africa, and has flagged a further $1.8 million capital raising.
Upvote Downvote

 
Zinc rally to spur Hindustan Zinc’s mine expansions: CEO Sunil Duggal

2017-03-24 livemint
A 57% gain in zinc prices over the past 12 months has helped Hindustan Zinc deliver a record return to shareholders
Upvote Downvote

 
Independence in Fraser Range JV with Orion

2017-03-10 businessnews.com.au
Gold and nickel miner Independence Group has expanded its presence in the Fraser Range after entering into an agreement to farm-in to Orion Gold’s tenements in the area for an initial $2 million in cash and scrip.
Upvote Downvote

 
Orion Gold NL to detail raising

2016-11-06 proactiveinvestors.com.au
Orion Gold NL's (ASX:ORN) shares have been a strong performer of late, last trading at $0.025, or double where they were at the beginning on June this year.
Upvote Downvote

 
Orion Gold continues high-grade zinc, copper hits in South Africa

2016-11-02 proactiveinvestors.com.au
This includes a highlight result of 9.3 metres at 4% zinc, 1.4% copper, 0.13 g/t gold and 9 g/t silver from 170 metres. The Prieska Project covers unmined dip and strike extensions from historical underground mining, with mineralisation having previously been delineated by extensive drilling and geophysics. The current drilling program is designed to confirm and extend the historical drilling at the +105 Level, where drilling is targeting mineralisation that would be amenable to open pit mining.
Upvote Downvote

 
Orion Gold makes steady progress at South African projects

2016-10-25 proactiveinvestors.com.au
Both projects are part of Orion’s extensive portfolio of projects within the Areachap Belt in the Northern Cape Province of South Africa. Drilling has already commenced at Kantienpan Zinc-Copper Deposit to test the recently discovered KN1 conductor identified by high-powered fixed loop ground electromagnetic surveys. The KN1 conductor is a strong, late channel conductor located down-dip of a shallow conductor detected in historical electromagnetic surveying.
Upvote Downvote

 
Orion Gold NL lays out nickel, copper targets at Fraser Range

2016-10-07 proactiveinvestors.com.au
Orion Gold NL (ASX:ORN) has generated significant new exploration targets from ongoing high-resolution geophysical surveys at its Fraser Range Nickel-Copper Project in Western Australia. While the data analysis is of a preliminary nature, clear areas of priority interest for potential magmatic nickel-copper mineralisation are already observable. Notably, the company has observed “eye” features that are characteristic of mafic-ultramafic intrusions in the Fraser Range Province.
Upvote Downvote

 
Orion Gold NL lays out nickel, copper targets at Fraser Range

2016-10-06 proactiveinvestors.com.au
Orion Gold NL (ASX:ORN) has generated significant new exploration targets from ongoing high-resolution geophysical surveys at its Fraser Range Nickel-Copper Project in Western Australia. While the data analysis is of a preliminary nature, clear areas of priority interest for potential magmatic nickel-copper mineralisation are already observable. Notably, the company has observed “eye” features that are characteristic of mafic-ultramafic intrusions in the Fraser Range Province.
Upvote Downvote

 
Orion Gold NL's maiden drilling hits broad zinc in South Africa

2016-09-13 proactiveinvestors.com.au
Orion Gold NL (ASX:ORN) has received significant results from an ongoing maiden drilling program at the historical Prieska Copper Mine zinc-copper project in South Africa. The drilling is continuing to intersect wide zones of high grade zinc-copper mineralisation including 42 metres at 4.41% zinc, 2.36% copper, 0.42g/t gold and 14 g/t silver from 55 metres. The work is currently underway to establish a maiden mineral resource estimate.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...